Complicated Malaria

Introduction And Etiology

Complicated or severe malaria represents a life-threatening medical emergency defined by the presence of asexual parasitemia accompanied by one or more severe clinical complications.
While Plasmodium falciparum remains the primary etiologic agent for severe disease, Plasmodium vivax and Plasmodium knowlesi are increasingly recognized as significant causes of complicated malaria.
The condition carries a high mortality rate of approximately 20% if prompt and appropriate treatment is not instituted.

Cytoadherence And Sequestration: Infected red blood cells develop distinct surface knobs, facilitating adherence to the vascular endothelium within deep organs such as the brain, kidneys, and lungs. This mechanism prevents splenic clearance and triggers microvascular obstruction, culminating in profound tissue anoxia and organ dysfunction.
Rosetting: Uninfected red blood cells clump to infected red blood cells, further exacerbating the blockade of microvascular blood flow.
Cytokine Storm: The rupture of schizonts releases parasitic toxins, stimulating an excessive host overproduction of proinflammatory cytokines, notably Tumor Necrosis Factor-alpha and Interleukin-1. These mediators directly drive fever, hypoglycemia, bone marrow suppression, and severe tissue injury.
Hemolysis: Extensive destruction involving both infected and uninfected red blood cells leads to severe, rapidly progressive anemia.

The World Health Organization defines severe malaria by the presence of parasitemia along with specific life-threatening complications.

Complication Category	Clinical And Laboratory Defining Features
Cerebral Malaria	Impaired consciousness presenting as unarousable coma (Blantyre Coma Score <3 or Glasgow Coma Scale <11) not attributable to other etiologies. Malarial retinopathy serves as a highly specific confirmatory sign.
Severe Anemia	Hemoglobin levels dropping below 5 g/dL (or hematocrit <15%) in children under 12 years of age.
Respiratory Distress	Deep, labored, acidotic breathing (Kussmaul’s respiration) indicative of metabolic acidosis, serving as a major mortality predictor.
Hypoglycemia	Blood glucose dropping below 40 mg/dL, occurring commonly in pediatric populations.
Algid Malaria (Shock)	Hemodynamic instability marked by delayed capillary refill $\geq$ 3 seconds, abnormal temperature gradients on limbs, or systolic blood pressure <70 mm Hg in children.
Renal Impairment	Acute kidney injury characterized by plasma creatinine exceeding 3 mg/dL or urea exceeding 20 mmol/L.
Other Hallmarks	Multiple convulsions (>2 episodes within 24 hours), clinical jaundice (bilirubin >3 mg/dL), hyperparasitemia (>10% infected red blood cells), bleeding diathesis due to Disseminated Intravascular Coagulation, and macroscopic hemoglobinuria termed Blackwater fever.

Severe malaria mandates immediate hospitalization, preferably within an intensive care unit setting.
Secure the airway in comatose patients and administer oxygen for any signs of respiratory distress.
Treat shock utilizing careful fluid resuscitation, strictly avoiding fluid overload to prevent iatrogenic pulmonary edema.
Implement rigorous monitoring of blood glucose every 4 hours, alongside vital signs and coma scores.

Regimen Type	Pharmacological Guidelines
First-Line Therapy	Intravenous Artesunate administered at 2.4 mg/kg at 0, 12, and 24 hours, followed by once-daily dosing. This regimen reduces mortality by approximately 25% compared to quinine.
Alternative Therapy	Intravenous Quinine administered with a loading dose of 20 mg salt/kg over 4 hours, followed by a maintenance dose of 10 mg salt/kg every 8 hours. Requires strict cardiac monitoring for QT prolongation and glucose monitoring due to insulin-release stimulation.
Step-Down Therapy	Transition to a full therapeutic course of oral Artemisinin-based Combination Therapy once the patient demonstrates tolerance for oral medications.

Hypoglycemia: Correct immediately utilizing an intravenous 10% Dextrose bolus at 2 to 5 mL/kg.
Seizures: Manage promptly with intravenous Benzodiazepines, specifically Diazepam (0.3 to 0.5 mg/kg) or Lorazepam (0.1 mg/kg).
Severe Anemia: Transfuse packed red blood cells at 10 mL/kg if hemoglobin falls below 5 g/dL, or below 7 g/dL if concurrent respiratory distress is present.

The administration of corticosteroids, heparin, and prophylactic phenobarbitone is strictly contraindicated as they offer no benefit and cause harm.
Exchange transfusion is no longer recommended due to an established lack of survival benefit.